Literature DB >> 7903874

Interleukin-12 induces tyrosine phosphorylation and activation of 44-kD mitogen-activated protein kinase in human T cells.

C Pignata1, J S Sanghera, L Cossette, S L Pelech, J Ritz.   

Abstract

Interleukin-12 (IL-12) is a novel cytokine that enhances numerous functional activities of human T cells and natural killer (NK) cells. The present studies were undertaken to characterize some of the early signaling events following IL-12 stimulation of mitogen-activated normal T cells. In these cells, IL-12 induces rapid tyrosine phosphorylation of proteins of 21, 44, and 54 kD. However, IL-12 does not induce tyrosine phosphorylation in normal resting T cells. In conjunction with increased tyrosine phosphorylation of several substrates, IL-12 stimulation resulted in increased in vitro kinase activity of immunoprecipitated tyrosine phosphorylated proteins. The 44-kD protein has been characterized as one isoform of the mitogen-activated protein (MAP) kinase family. Increased tyrosine phosphorylation of MAP kinase following IL-12 stimulation was also associated with enhanced enzymatic activity of this protein in vitro as measured by myelin basic protein phosphotransferase assay. These studies identify MAP kinase as one of the intracellular elements of the IL-12 signaling pathway in human T cells.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7903874

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  7 in total

1.  Cloning of murine Stat6 and human Stat6, Stat proteins that are tyrosine phosphorylated in responses to IL-4 and IL-3 but are not required for mitogenesis.

Authors:  F W Quelle; K Shimoda; W Thierfelder; C Fischer; A Kim; S M Ruben; J L Cleveland; J H Pierce; A D Keegan; K Nelms
Journal:  Mol Cell Biol       Date:  1995-06       Impact factor: 4.272

2.  Differential distribution of both IL-12Rbeta chains in the plasma membrane of human T cells.

Authors:  Ana Canda-Sánchez; Francisco J Salgado; Amparo Pérez-Díaz; Carla Varela-González; Pilar Arias; Montserrat Nogueira
Journal:  J Membr Biol       Date:  2008-12-09       Impact factor: 1.843

3.  Interleukin 12 induces tyrosine phosphorylation and activation of STAT4 in human lymphocytes.

Authors:  C M Bacon; E F Petricoin; J R Ortaldo; R C Rees; A C Larner; J A Johnston; J J O'Shea
Journal:  Proc Natl Acad Sci U S A       Date:  1995-08-01       Impact factor: 11.205

4.  Interleukin 12 signaling in T helper type 1 (Th1) cells involves tyrosine phosphorylation of signal transducer and activator of transcription (Stat)3 and Stat4.

Authors:  N G Jacobson; S J Szabo; R M Weber-Nordt; Z Zhong; R D Schreiber; J E Darnell; K M Murphy
Journal:  J Exp Med       Date:  1995-05-01       Impact factor: 14.307

5.  Residual type 1 immunity in patients genetically deficient for interleukin 12 receptor beta1 (IL-12Rbeta1): evidence for an IL-12Rbeta1-independent pathway of IL-12 responsiveness in human T cells.

Authors:  C E Verhagen; H H Smits; F A Verreck; E A Wierenga; M Kurimoto; D A Lammas; D S Kumararatne; O Sanal; F P Kroon; F Sinigaglia; T H Ottenhoff
Journal:  J Exp Med       Date:  2000-08-21       Impact factor: 14.307

6.  Interleukin 12 (IL-12) induces tyrosine phosphorylation of JAK2 and TYK2: differential use of Janus family tyrosine kinases by IL-2 and IL-12.

Authors:  C M Bacon; D W McVicar; J R Ortaldo; R C Rees; J J O'Shea; J A Johnston
Journal:  J Exp Med       Date:  1995-01-01       Impact factor: 14.307

7.  Identification of Sorafenib as a Treatment for Type 1 Diabetes.

Authors:  Qin Zeng; Jianfeng Song; Dandan Wang; Xiaoxiao Sun; Yalun Xiao; Haowei Zhang; Yang Xiao; Zhiguang Zhou; Tuo Deng
Journal:  Front Immunol       Date:  2022-02-15       Impact factor: 7.561

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.